ksRepo: A generalized platform for computational drug repositioning

BMC Bioinformatics

Volumn 17, Issue 1, 2016, Pages

  Brown, Adam S ^a   Kong, Sek Won ^b   Kohane, Isaac S ^a   Patel, Chirag J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Drug discovery; Gene expression; Prostate cancer; Repositioning

Indexed keywords

DATABASE SYSTEMS; DISEASES; GENES; UROLOGY;

CHEMICAL EXPOSURE; COMPUTATIONAL TECHNIQUE; DRUG DISCOVERY; DRUG REPOSITIONING; GENE EXPRESSION DATA; PHARMACEUTICAL INDUSTRY; PROSTATE CANCERS; REPOSITIONING;

GENE EXPRESSION;

DRUG;

BIOLOGY; CHEMISTRY; COMPUTER SIMULATION; DRUG REPOSITIONING; FACTUAL DATABASE; GENETICS; HUMAN; MALE; PROCEDURES; PROSTATIC NEOPLASMS; SOFTWARE; THEORETICAL MODEL; TOXICOGENETICS;

COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DATABASES, FACTUAL; DRUG REPOSITIONING; HUMANS; MALE; MODELS, THEORETICAL; PHARMACEUTICAL PREPARATIONS; PROSTATIC NEOPLASMS; SOFTWARE; TOXICOGENETICS;

EID: 84960107641     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/s12859-016-0931-y     Document Type: Article

References (30)

1. Readhead B, Dudley J. Translational bioinformatics approaches to drug development. Adv Wound Care (New Rochelle). 2013;2(9):470-89.
2. Jin G, Wong STC. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today. 2014;19(5):637-44.
3. Shim JS, Liu JO. Recent advances in drug repositioning for the discovery of new anticancer drugs. Int J Biol Sci. 2014;10(7):654-63.
4. Stenvang J, Kümler I, Nygård SB, Smith DH, Nielsen D, Brünner N, et al. Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development. Front Oncol. 2013;3:313.
5. Munson J, Bonner M, Fried L, Hofmekler J, Arbiser J, Bellamkonda R. Identifying new small molecule anti-invasive compounds for glioma treatment. Cell Cycle. 2013;12(14):2200-9.
6. Bellera CL, Sbaraglini ML, Balcazar DE, Fraccaroli L, Vanrell MC, Casassa AF, et al. High-throughput drug repositioning for the discovery of new treatments for Chagas disease. Mini Rev Med Chem. 2015;15(3):182-93.
7. Shu C-W, Liu P-F, Huang C-M. High throughput screening for drug discovery of autophagy modulators. Comb Chem High Throughput Screen. 2012;15(9):721-9.
8. Li J, Zheng S, Chen B, Butte AJ, Swamidass SJ, Lu Z. A survey of current trends in computational drug repositioning. Brief Bioinform. 2016 Jan;17(1):2-12.
9. Menden MP, Iorio F, Garnett M, McDermott U, Benes CH, Ballester PJ, et al. Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties. PLoS One. 2013;8(4), e61318.
10. Gottlieb A, Stein GY, Ruppin E, Sharan R. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011;7:496.
11. Grover MP, Ballouz S, Mohanasundaram KA, George RA, Sherman CDH, Crowley TM, et al. Identification of novel therapeutics for complex diseases from genome-wide association data. BMC Med Genomics. 2014;7 Suppl 1:S8.
12. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929-35.
13. Huang H, Nguyen T, Ibrahim S, Shantharam S, Yue Z, Chen JY. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates. BMC Bioinformatics. 2015;16 Suppl 13:S4.
14. Yu J, Putcha P, Silva JM. Recovering drug-induced apoptosis subnetwork from Connectivity Map data. Biomed Res Int. 2015;2015:708563.
15. Lv J, Zhu B, Zhang L, Xie Q, Zhuo W. Detection and screening of small molecule agents for overcoming Sorafenib resistance of hepatocellular carcinoma: a bioinformatics study. Int J Clin Exp Med. 2015;8(2):2317-25.
16. Zhang M, Luo H, Xi Z, Rogaeva E. Drug repositioning for diabetes based on "omics" data mining. PLoS One. 2015;10(5), e0126082.
17. Manzotti G, Parenti S, Ferrari-Amorotti G, Soliera AR, Cattelani S, Montanari M, et al. Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database. Cell Cycle. 2015 Jun 23;0
18. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol. 2004;22(14):2790-9.
19. Arredouani MS, Lu B, Bhasin M, Eljanne M, Yue W, Mosquera J-M, et al. Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer. Clin Cancer Res. 2009;15(18):5794-802.
20. Satake H, Tamura K, Furihata M, Anchi T, Sakoda H, Kawada C, et al. The ubiquitin-like molecule interferon-stimulated gene 15 is overexpressed in human prostate cancer. Oncol Rep. 2010;23(1):11-6.
21. Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, et al. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res. 2008;68(21):8954-67.
22. Nanni S, Priolo C, Grasselli A, D'Eletto M, Merola R, Moretti F, et al. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer. Mol Cancer Res. 2006;4(2):79-92.
23. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets-update. Nucl Acids Res [Internet]. 2013 1 [cited 2015 Jun 26];41(D1):D991-D995.
24. Davis AP, Grondin CJ, Lennon-Hopkins K, Saraceni-Richards C, Sciaky D, King BL, et al. The Comparative Toxicogenomics Database's 10th year anniversary: update 2015. Nucleic Acids Res. 2015;43(Database issue):D914-20.
25. The R team. R: a language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria. 2008.
26. Carlson M. org.Hs.eg.db: Genome wide annotation for Human. R package version 3.1.2 2015.
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289-300.
28. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34(Database issue):D668-72.
29. Lam JS, Leppert JT, Vemulapali SN, Shvarts O, Belldegrun AS. Secondary hormonal therapy for advanced prostate cancer. J Urol. 2006;175(1):27-34.
30. Thorn CF, Klein TE, Altman RB. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base. Methods Mol Biol. 2005;311:179-91.